Random-forest selection links a food compound to COX-1 inhibition
A random-forest model prioritized 5-methoxysalicylic acid for a COX-1 enzyme assay. It showed about 40% inhibition at 100 micromolar, whereas a higher-ranked single-fingerprint comparator did not inhibit at that concentration. This is a modest in-vitro target result, not evidence of dietary, therapeutic or clinical benefit.
Technology: Random-forest classification of drug-target similarity
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: An enzymatic assay compared the selected compound with positive and negative controls.
- Still unknown: Cellular target engagement, efficacy and a robust compound IC50 are not established here.
- AI role: Random-forest classification of drug-target similarity supported the stated study; experimental and interpretive work remained with researchers.
Evidence sources: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1010029
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 16 Nov 2026. Review scope: Primary publisher abstract, selected model training and assay Results, publication date and affiliations; supplementary data not reviewed..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.